Valuation: Arcoma AB

Market Cap 121M 12.53M 10.95M 10.1M 9.31M 17.55M 1.21B 17.94M 47.5M 591M 47.05M 46.02M 2.03B P/E 2024
12.7x
P/E 2025 20.9x
Enterprise Value 85.54M 8.87M 7.76M 7.16M 6.6M 12.43M 855M 12.71M 33.64M 419M 33.33M 32.6M 1.44B EV / Sales 2024
0.82x
EV / Sales 2025 0.53x
Free-Float
52.21%
Yield 2024 *
-
Yield 2025 -
1 day-1.40%
1 week+4.71%
Current month-5.38%
1 month-4.52%
3 months+0.24%
6 months+9.33%
Current year+14.99%
1 week 7.56
Extreme 7.56
8.96
1 month 7.02
Extreme 7.02
9.26
Current year 6.16
Extreme 6.16
10.05
1 year 6.16
Extreme 6.16
11
3 years 6.16
Extreme 6.16
18.3
5 years 6.16
Extreme 6.16
20.2
10 years 3.57
Extreme 3.57
26.3
Manager TitleAgeSince
Chief Executive Officer 45 01/01/2023
Director of Finance/CFO 42 01/01/2022
Chief Tech/Sci/R&D Officer - 01/06/2026
Director TitleAgeSince
Director/Board Member 55 01/01/2012
Chairman 54 01/01/2017
Director/Board Member 59 01/01/2022
Change 5-day change 1-year change 3-year change Capi.($)
-1.40%+4.71%-17.25%-12.99% 12.53M
-1.21%+1.26%-13.71%-19.02% 13.35B
-6.37%-15.89%+41.04%-11.18% 3.86B
-0.76%-0.17%+71.16%+109.12% 1.24B
-4.45%-0.26%-35.24%-60.78% 1.18B
-4.35%-2.94%-40.50%-47.30% 1.09B
-3.75%+6.82%-42.81% - 940M
-8.55%-20.41%+61.00%+89.90% 490M
+5.01%+12.02%+47.47% - 335M
+1.55%+1.73%-56.66%+239.01% 265M
Average -2.43%+0.36%+1.45%+35.84% 2.28B
Weighted average by Cap. -2.52%-0.29%-1.41%-8.29%

Financials

2024 2025
Net sales 157M 16.27M 14.22M 13.12M 12.09M 22.79M 1.57B 23.3M 61.68M 767M 61.1M 59.76M 2.64B 131M 13.57M 11.86M 10.94M 10.09M 19.01M 1.31B 19.43M 51.45M 640M 50.96M 49.85M 2.2B
Net income 11.18M 1.16M 1.01M 935K 862K 1.62M 112M 1.66M 4.4M 54.7M 4.36M 4.26M 188M 5.03M 522K 456K 421K 388K 731K 50.26M 747K 1.98M 24.61M 1.96M 1.92M 84.73M
Net Debt -13.32M -1.38M -1.21M -1.11M -1.03M -1.94M -133M -1.98M -5.24M -65.16M -5.19M -5.07M -224M -35.23M -3.65M -3.19M -2.95M -2.72M -5.12M -352M -5.23M -13.86M -172M -13.73M -13.42M -593M
Logo Arcoma AB
Arcoma AB is a Sweden-based medical technology company. It develops, produces and markets digital radiographic systems. Its products offer digital imaging technology combined with advanced mobile positioning system. The Company's product portfolio comprises: complete radiographic systems available as ceiling suspensions and floor mounted systems, as well as detectors; radiographic system components, such as overhead tube crane, cube, tilting wall stand and radiographic tables; and mobile imaging tables in two series, namely Precision and Elite. Its products are designed for hospitals, clinics, imaging centers and private practices, and available through three market channels: its own brand IMIX, private label distributors and original equipment manufacturers (OEM).
Employees
31
Date Price Change Volume
17/07/26 SEK 8.440 -1.40% 2,493
16/07/26 SEK 8.560 -1.38% 3,135
15/07/26 SEK 8.680 +4.83% 165
14/07/26 SEK 8.280 +2.99% 102
13/07/26 SEK 8.040 -0.25% 15,994

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ARCOMA Stock